114 related articles for article (PubMed ID: 10774257)
1. [Pharmacological role of isatin, an endogenous MAO inhibitor].
Hamaue N
Yakugaku Zasshi; 2000 Apr; 120(4):352-62. PubMed ID: 10774257
[TBL] [Abstract][Full Text] [Related]
2. [Effects of isatin, an endogenous MAO inhibitor, on dopamine (DA) and acetylcholine (ACh) concentrations in rats].
Minami M; Hamaue N; Endo T; Hirafuji M; Terado M; Ide H; Yamazaki N; Yoshioka M; Ogata A; Tashiro K
Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():186P-191P. PubMed ID: 10629878
[TBL] [Abstract][Full Text] [Related]
3. Role of an endogenous monoamine oxidase inhibitor, isatin, in SHRSP brain.
Hamaue N; Endo T; Hirafuji M; Yamazaki N; Togashi H; Saito H; Minami M
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S86-7. PubMed ID: 9072455
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus.
Hamaue N; Minami M; Terado M; Hirafuji M; Endo T; Machida M; Hiroshige T; Ogata A; Tashiro K; Saito H; Parvez SH
Neurotoxicology; 2004 Jan; 25(1-2):205-13. PubMed ID: 14697895
[TBL] [Abstract][Full Text] [Related]
5. Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson's disease induced by the Japanese encephalitis virus.
Minami M; Hamaue N; Hirafuji M; Saito H; Hiroshige T; Ogata A; Tashiro K; Parvez SH
J Neural Transm Suppl; 2006; 71(71):87-95. PubMed ID: 17447419
[TBL] [Abstract][Full Text] [Related]
6. Determination of isatin, an endogenous monoamine oxidase inhibitor, in urine and tissues of rats by HPLC.
Hamaue N; Yamazaki N; Minami M; Endo T; Hirahuji M; Monma Y; Togashi H
Gen Pharmacol; 1998 Mar; 30(3):387-91. PubMed ID: 9510091
[TBL] [Abstract][Full Text] [Related]
7. Isatin, an endogenous MAO inhibitor, improves bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
Ogata A; Hamaue N; Terado M; Minami M; Nagashima K; Tashiro K
J Neurol Sci; 2003 Jan; 206(1):79-83. PubMed ID: 12480089
[TBL] [Abstract][Full Text] [Related]
8. [Monoamine oxidase, tribulin, isatin: basic and applied medical aspects].
Medvedev AE
Vestn Ross Akad Med Nauk; 1999; (10):45-8. PubMed ID: 10578664
[TBL] [Abstract][Full Text] [Related]
9. Effects and mechanism of action of isatin, a MAO inhibitor, on in vivo striatal dopamine release.
Justo LA; Durán R; Alfonso M; Fajardo D; Faro LRF
Neurochem Int; 2016 Oct; 99():147-157. PubMed ID: 27374845
[TBL] [Abstract][Full Text] [Related]
10. Urinary isatin concentrations in patients with Parkinson's disease determined by a newly developed HPLC-UV method.
Hamaue N; Yamazaki N; Terado M; Minami M; Ohno K; Ide H; Ogata A; Honma S; Tashiro K
Res Commun Mol Pathol Pharmacol; 2000; 108(1-2):63-73. PubMed ID: 11758976
[TBL] [Abstract][Full Text] [Related]
11. Effects of some anxiogenic agents on rat brain monoamine oxidase (MAO) A and B inhibitory (tribulin) activity.
Bhattacharya SK; Chakrabarti A; Sandler M; Glover V
Indian J Exp Biol; 1996 Dec; 34(12):1190-3. PubMed ID: 9246908
[TBL] [Abstract][Full Text] [Related]
12. Function of endogenous monoamine oxidase inhibitors (tribulin).
Glover V
J Neural Transm Suppl; 1998; 52():307-13. PubMed ID: 9564631
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic effects of isatin: an endogenous MAO inhibitor related to tribulin.
McIntyre IM; Norman TR
J Neural Transm Gen Sect; 1990; 79(1-2):35-40. PubMed ID: 1688707
[TBL] [Abstract][Full Text] [Related]
14. Effects of isatin on rotational behavior and DA levels in caudate putamen in Parkinsonian rats.
Zhou Y; Zhao ZQ; Xie JX
Brain Res; 2001 Oct; 917(1):127-32. PubMed ID: 11602237
[TBL] [Abstract][Full Text] [Related]
15. Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin.
Glover V; Halket JM; Watkins PJ; Clow A; Goodwin BL; Sandler M
J Neurochem; 1988 Aug; 51(2):656-9. PubMed ID: 3392550
[TBL] [Abstract][Full Text] [Related]
16. Isatin and tribulin concentrations are increased in rabbit brain but not liver following pentylenetetrazole administration.
Clow A; Davidson J; Glover V; Halket JM; Milton AS; Sandler M; Watkins PJ
Neurosci Lett; 1989 Dec; 107(1-3):327-30. PubMed ID: 2616043
[TBL] [Abstract][Full Text] [Related]
17. Participation of glutamatergic and nitrergic systems in the striatal dopamine release induced by isatin, a MAO inhibitor.
Faro LRF; Justo L; Gómez R; Durán R
Eur J Neurosci; 2021 Aug; 54(3):4729-4739. PubMed ID: 34022091
[TBL] [Abstract][Full Text] [Related]
18. The effect of isatin (tribulin) on metabolism of indoles in the rat brain and pineal: in vitro and in vivo studies.
Yuwiler A
Neurochem Res; 1990 Jan; 15(1):95-100. PubMed ID: 1691454
[TBL] [Abstract][Full Text] [Related]
19. Effect of aromatic amino acids, pentylenetetrazole and yohimbine on isatin and tribulin activity in rat brain.
Bhattacharya SK; Clow A; Przyborowska A; Halket J; Glover V; Sandler M
Neurosci Lett; 1991 Oct; 132(1):44-6. PubMed ID: 1787917
[TBL] [Abstract][Full Text] [Related]
20. Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cells.
Igosheva N; Lorz C; O'Conner E; Glover V; Mehmet H
Neurochem Int; 2005 Aug; 47(3):216-24. PubMed ID: 15876476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
